Feature Channels: AIDS and HIV

Filters close
Released: 17-Dec-2021 11:05 AM EST
Study shows how HIV copies itself in the body
Ohio State University

HIV replication in the human body requires that specific viral RNAs be packaged into progeny virus particles. A new study has found how a small difference in the RNA sequence can allow the viral RNA to be packaged for replication, creating potential targets for future HIV treatments.

Newswise: Bridging the health care communications gap for transgender men
Released: 16-Dec-2021 2:40 PM EST
Bridging the health care communications gap for transgender men
University of Texas Health Science Center at Houston

Transgender men face significant health and social disparities, including barriers to health care, research, and essential HIV-related conversations with their health care providers. That is why Paige Wermuth, PhD, MPH, assistant professor in the Department of Management, Policy, and Community Health, and graduate student Lou Weaver of The University of Texas Health Science Center (UTHealth Houston) School of Public Health are launching a pilot project to examine and develop communication materials for trans men and their health care providers regarding HIV prevention.

Released: 14-Dec-2021 8:05 PM EST
HVTN Faith Initiative expands to help build bridges between community and HIV vaccine trials
HIV Vaccine Trials Network

While the rapid development of effective vaccines has helped combat the COVID-19 pandemic, key communities – especially people who are living with HIV – remain disproportionately impacted, and are at higher risk of severe disease and death. Finding an effective HIV vaccine is critically important, and to that end, the HIV Vaccine Trials Network (HVTN) is launching an expanded Faith Initiative that will help advance the work of finding a cure.

Released: 14-Dec-2021 10:35 AM EST
Duke Institute Lands Federal Contract to Make Vaccine Candidates
Duke Health

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

Released: 13-Dec-2021 1:25 PM EST
Landmark COVID-19 vaccine trial in sub-Saharan Africa is the first to study the efficacy of mRNA COVID-19 vaccines in people living with HIV
Covid-19 Prevention Network (CoVPN)

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections. It also is the first study to evaluate the efficacy of vaccines – in this case, Moderna mRNA-1273 – against the omicron variant of SARS-CoV-2, the virus that causes COVID-19.

Newswise: UTEP to Work on Solutions to Reduce Drug Use-Related HIV in the El Paso-Ciudad Juárez Border
Released: 10-Dec-2021 3:00 PM EST
UTEP to Work on Solutions to Reduce Drug Use-Related HIV in the El Paso-Ciudad Juárez Border
University of Texas at El Paso

The University of Texas at El Paso will develop a sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juárez border region. The initiative will be funded by a $3 million grant from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA).

Released: 8-Dec-2021 11:05 AM EST
Racial Bias among Doctors May Exacerbate Disparities in HIV Prevention, Rutgers-led Study Finds
Rutgers University-New Brunswick

Racial bias among health care providers may limit the number of Black women who could be taking a daily pill to prevent HIV infection, according to a Rutgers-led study.

Newswise: Meth use, intimate partner violence weaken immune function in HIV-positive men
Released: 3-Dec-2021 4:05 PM EST
Meth use, intimate partner violence weaken immune function in HIV-positive men
University of California, Los Angeles (UCLA), Health Sciences

Among HIV-positive black and Latino men who have sex with men, the use of methamphetamine combined with intimate partner violence may increase the risk for developing chronic diseases such as cardiovascular disease and other disorders.

Newswise: Media,1246255,smxx.png
30-Nov-2021 10:05 AM EST
First long-acting option HIV prevention approved for use - Worlds AIDS Day
Queen's University Belfast

The first long-acting option to protect women from HIV, proven to reduce women’s HIV risk, has been recommended for use by the World Health Organization (WHO).

Newswise: On World AIDS Day, COVID-19 Vaccines Are Critical
Released: 30-Nov-2021 4:00 PM EST
On World AIDS Day, COVID-19 Vaccines Are Critical
American Thoracic Society (ATS)

Dec. 1, 2021— People living with HIV experience more severe outcomes and have higher comorbidities from COVID-19 than people not living with HIV, according to the 2020 UNAIDS Global Update. In mid-2021, most people living with HIV did not have access to COVID-19 vaccines. This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on governments, health advocates and non-government organisations to strengthen their response to AIDS and COVID-19 by making COVID-19 vaccines more accessible worldwide.

Released: 30-Nov-2021 11:15 AM EST
Population of People with HIV on Treatment in U.S. Projected to Keep Increasing Through 2030
Johns Hopkins Bloomberg School of Public Health

In a baseline scenario, the researchers project a rise in the ART-using population from about 670,000 in 2020 to nearly 910,000 by the end of 2030 if current trends in new HIV infections persist.  

Newswise: Einstein and Montefiore Researchers Awarded $7.6 Million in NIH Grants to Study Depression in People Living with HIV
Released: 18-Nov-2021 11:00 AM EST
Einstein and Montefiore Researchers Awarded $7.6 Million in NIH Grants to Study Depression in People Living with HIV
Albert Einstein College of Medicine

The Bronx is home to more than 27,000 people living with HIV, the majority of whom are Black or Hispanic men. People living with HIV have an increased risk for depression and substance use, which in turn can make adhering to daily antiviral treatments difficult, negatively impacting both quality of life and overall health. Now, the National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System two five-year grants totaling $7.6 million to study the structural and chemical changes in the brain of people living with HIV, depression, and cannabis use disorder.

Newswise: Abdel-Mohsen%2C%20Mohamed.jpg
11-Nov-2021 1:05 PM EST
Wistar Scientists Discover Sugar Molecule on HIV-infected Cell Plays Role in Evading Immune System — They Exploit as Weakness to Make More Effective “Natural Killers” Against HIV
Wistar Institute

A new Wistar Institute study shows how key features on the surface of HIV-infected cells help the disease evade detection by the immune system.

Released: 9-Nov-2021 3:35 PM EST
Rutgers Launches IMPOWER HIV Prevention Studies in Newark
Rutgers University-New Brunswick

Rutgers New Jersey Medical School’s Research with a Heart is recruiting participants for the MERCK– IMPOWER studies to assess an HIV prevention oral medication on sexual minority groups.

5-Nov-2021 11:05 AM EDT
New Study Suggests Healthcare Provider Biases Can Impact a Patient’s Access to Preventative HIV Drug
George Washington University

A new study published today reveals systematic biases among primary and HIV care providers about people who inject drugs and how those biases may impact access to pre-exposure prophylaxis (PrEP), a preventive, prescription-based medication that significantly reduces the risk of HIV infection through sexual behavior and injection practices.

Newswise: Not So Great Expectations: Pain in HIV Related to Brain’s Expectations of Relief
Released: 4-Nov-2021 11:35 AM EDT
Not So Great Expectations: Pain in HIV Related to Brain’s Expectations of Relief
University of California San Diego Health

Neuroimaging study reveals potential brain mechanism underlying chronic neuropathic pain in individuals with HIV. Findings may guide new clinical treatments targeting patients’ expectations for pain relief.

Newswise: NSU Research Scientist Leads Group That Discovered Gene Variants That Delimit HIV-1 Infection
Released: 2-Nov-2021 9:00 AM EDT
NSU Research Scientist Leads Group That Discovered Gene Variants That Delimit HIV-1 Infection
Nova Southeastern University

The new study provides valuable insights into the genetic variants associated with HIV-1C infection and AIDS progression in sub-Saharan Africa, potentially paving the way for new therapies.

Newswise: adobestock-168409297___25155515021.jpg
Released: 25-Oct-2021 4:05 PM EDT
Public Health x Art
Rutgers School of Public Health

The Rutgers School of Public Health and the Mason Gross School of the Arts have launched a collaboration to support community-engaged, arts-integrated research projects that will result in performances or productions of art.

Newswise: Case Western Reserve University receives $16M federal grant to launch major research center on substance use and HIV
Released: 25-Oct-2021 3:40 PM EDT
Case Western Reserve University receives $16M federal grant to launch major research center on substance use and HIV
Case Western Reserve University

Thanks to a new $16 million, five-year grant from the National Institute on Drug Abuse of the National Institutes of Health, Case Western Reserve University is launching a multi-institutional research effort dedicated to deepening understanding of the relationship between substance use and HIV.

Released: 25-Oct-2021 11:00 AM EDT
UAlbany Receives $1M for Program to Prevent HIV and Substance Abuse
University at Albany, State University of New York

The University at Albany has been awarded $1 million for the creation of a five-year, comprehensive program aimed at preventing HIV infections and substance use disorders among students.

Newswise: Virtual Village Treats HIV-associated Loneliness in Novel UC San Diego Health Trial
Released: 21-Oct-2021 2:05 PM EDT
Virtual Village Treats HIV-associated Loneliness in Novel UC San Diego Health Trial
University of California San Diego Health

A new trial by UC San Diego Health infectious disease specialist Maile Young Karris, MD, will use longitudinal questionnaires and qualitative interviews to assess the impact of living in an interconnected virtual village on the loneliness known to afflict older people with HIV.

Newswise: Einstein-Developed Treatment Strategy May Lead to HIV Cure
21-Oct-2021 11:50 AM EDT
Einstein-Developed Treatment Strategy May Lead to HIV Cure
Albert Einstein College of Medicine

Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections. Their findings were published today in the Journal of Clinical Investigation.

Released: 21-Oct-2021 10:00 AM EDT
Crisis pregnancy centers may be hurting public health efforts
University of Georgia

In recent years, crisis pregnancy centers (CPCs) have begun to offer some STI and HIV services, but new research from the University of Georgia suggests that these services may actually be hurting public health efforts to prevent and treat these infections.

Released: 14-Oct-2021 9:45 AM EDT
Dr. Anthony Fauci and Philadelphia FIGHT’s Jane Shull Receive Wistar Legacy Award at 25th Anniversary of Jonathan Lax Memorial Lecture
Wistar Institute

Wistar is proud to announce Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Jane Shull, chief executive officer of Philadelphia FIGHT; philanthropist Ken Nimblett; Philadelphia Foundation and the Robert I. Jacobs Fund; and Philadelphia FIGHT will be honored at the Wistar Legacy Awards, a celebration of 25 years of continuous HIV research collaboration on Thursday, October 28 from 5:30 to 7:45 p.m.

Released: 5-Oct-2021 9:00 AM EDT
Professor collaborates on $3.1 million grant to address HIV in African American/Black and Latinx youth
Binghamton University, State University of New York

A new $3.1-million, four-year grant co-led by faculty at Binghamton University, State University of New York could help African American and Latinx youth living with HIV.

28-Sep-2021 1:30 PM EDT
Gene Found in Monkeys and Mice Could Work as a New Type of Antiviral to Block HIV, Ebola, and Other Deadly Viruses in Humans
University of Utah Health

A nationwide team of researchers, led by scientists at University of Utah Health and The Rockefeller University, has determined how a genetic mutation found in mice and monkeys interferes with viruses such as HIV and Ebola. They say the finding could eventually lead to the development of medical interventions in humans.

Released: 29-Sep-2021 7:05 AM EDT
New antibody-based treatment could cure HIV
Uniformed Services University of the Health Sciences (USU)

Researchers at the Uniformed Services University of the Health Sciences (USU) and Université de Montréal, Canada have discovered a way to potentially eliminate HIV-1 infection in infected individuals by using a new type of antibody-based therapeutics, according to a new study published Sept. 29 in mBio.

Released: 14-Sep-2021 2:15 PM EDT
Proteins that outwit emerging and re-emerging viruses
Ohio State University

A family of proteins best known for their role in diminishing HIV infectivity may have the goods to outwit other emerging and re-emerging viruses, scientists have found.

Newswise: 9912_Anne_Teitelman_2016.rev.1572896600.jpg
Released: 8-Sep-2021 11:45 AM EDT
Article of the Year!
University of Pennsylvania School of Nursing

The Association of Nurses in AIDS Care (ANAC) honors research led by Anne Teitelman, PhD, FNP-BC, FAANP, FAAN, Associate Professor Emerita in Penn Nursing’s Department of Family and Community Health, as the 2021 JANAC (Journal of the Association of Nurses in AIDS Care) Article of the Year.

Released: 1-Sep-2021 4:05 PM EDT
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
Fred Hutchinson Cancer Research Center

SEATTLE — September 1, 2021 — Below are summaries of recent Fred Hutch research findings and other news.

Released: 31-Aug-2021 8:20 AM EDT
Experimental Phase 2b HIV Vaccine Regimen Provides Insufficient Protection in Preventing HIV
Fred Hutchinson Cancer Research Center

A primary analysis of an experimental HIV vaccine regimen being studied in a high-incidence population of young women in sub-Saharan Africa found the experimental vaccine did not provide sufficient protection against HIV infection.

Newswise: 177-kathryn-anastos.jpg
Released: 24-Aug-2021 11:25 AM EDT
Albert Einstein College of Medicine and City University of New York Researchers Receive $14.5 Million NIH Grant to Lead HIV Studies in Central Africa
Albert Einstein College of Medicine

Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy (CUNYSPH) have been awarded a five-year, $14.5 million grant from the National Institutes of Health (NIH) to continue leading and expand their research on HIV treatment and care in five Central African nations.

Newswise: Faculty Receives National Institutes of Health Grant to Assess the Implications of Opioid Use Among Older Adults Living with HIV
Released: 24-Aug-2021 11:00 AM EDT
Faculty Receives National Institutes of Health Grant to Assess the Implications of Opioid Use Among Older Adults Living with HIV
Rutgers School of Public Health

Rutgers School of Public Health assistant professor, Stephanie Shiau, has received a Career Development Award from the National Institute on Drug Abuse, part of the National Institutes of Health, to study the implications of opioid prescription use among older adults living with HIV.

Released: 24-Aug-2021 9:35 AM EDT
With short course of TB prevention for people living with HIV, completion soars
Ohio State University

People who are HIV positive and living in high tuberculosis-transmission regions of the world are much more likely to finish a TB-prevention regimen lasting just three months – half as long as the standard treatment, a large clinical trial in Africa has found.

Released: 19-Aug-2021 5:15 PM EDT
BIDMC researchers awarded $24.5 million by NIH to find a cure for HIV
Beth Israel Deaconess Medical Center

A team led by Dan H. Barouch, MD, PhD, has been awarded $4.9 million in annual funding over the next five years to find a cure for HIV. Barouch was one of ten primary investigators to receive a 2021 National Institutes of Health (NIH) Martin Delaney Collaboratories for HIV Cure Research award, which aims to expedite human immunodeficiency virus (HIV) cure research by bringing together research partners in academia, government, the private sector and the community; coordinating complex research studies, and mentoring the next generation of HIV cure researchers.

Newswise:Video Embedded breakthrough-cases-and-covid-boosters-live-expert-panel-for-august-18-2021
VIDEO
Released: 19-Aug-2021 3:00 PM EDT
VIDEO AND TRANSCRIPT AVAILABLE: Breakthrough Cases and COVID Boosters: Live Expert Panel for August 18, 2021
Newswise

Expert Q&A: Do breakthrough cases mean we will soon need COVID boosters? The extremely contagious Delta variant continues to spread, prompting mask mandates, proof of vaccination, and other measures. Media invited to ask the experts about these and related topics.

Released: 18-Aug-2021 1:30 PM EDT
For adults with HIV, lack of viral suppression linked to lower care engagement and increased barriers to care
Wolters Kluwer Health: Lippincott

More than one-third of U.S. adults with HIV are not virally suppressed. People who are not virally suppressed have lower engagement with HIV care and report more barriers to care, reports a study in the September/October issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: LuisMontaner.jpg
Released: 17-Aug-2021 12:25 PM EDT
The BEAT-HIV Collaboratory Receives More Than $29 Million in NIH Funding for HIV Cure Research
Wistar Institute

Wistar announces that the National Institutes of Health granted a five-year, $29.15 million Martin Delaney Collaboratories for HIV Cure Research award to the BEAT-HIV Martin Delaney Collaboratory to advance research towards a cure for HIV-1 Infection by Combination Immunotherapy.

Released: 16-Aug-2021 2:45 PM EDT
Should you get a third dose of COVID vaccine?
Michigan Medicine - University of Michigan

The FDA and CDC have just approved and recommended an additional dose of mRNA COVID-19 vaccines for moderately and severely immunocompromised people. Who should get it?

Newswise: Newsroom%20Aug%2011%20Image%20for%20Story%201_4_pyramid.jpg
Released: 11-Aug-2021 2:00 PM EDT
Hopkins Med News Update
Johns Hopkins Medicine

NEWS STORIES IN THIS ISSUE: - COVID-19 NEWS: Johns Hopkins Medicine Study Shows Vaccine Likely Protects People with HIV - Johns Hopkins Medicine Documents Stroke Risk in Cardiac Assist Device - CBD Products May Help People with Epilepsy Better Tolerate Anti-Seizure Medications

Newswise:Video Embedded miller-school-researcher-publishes-breakthrough-findings-on-nanoparticle-delivery-of-hivaids-medications-to-brain
VIDEO
Released: 11-Aug-2021 10:35 AM EDT
Miller School Researcher Publishes Breakthrough Findings on Nanoparticle Delivery of HIV/AIDS Medications to Brain
University of Miami Health System, Miller School of Medicine

A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems.

Newswise: Faculty Receive New Jersey Health Foundation Awards
Released: 4-Aug-2021 1:30 PM EDT
Faculty Receive New Jersey Health Foundation Awards
Rutgers School of Public Health

Rutgers School of Public Health faculty, Jaya Satagopan and Stephanie Shiau, have been named 2021 recipients of the New Jersey Health Foundation Excellence Awards.

Released: 8-Jul-2021 1:55 PM EDT
UCLA Fielding School Professor’s Team Awarded more than $5.2 Million in Grants for HIV Prevention
UCLA Fielding School of Public Health

A team of researchers co-led by UCLA Fielding School of Public Health epidemiology professor Dr. Matthew Mimiaga has received more than $5.2 million in grants from the U.S. National Institutes of Health (NIH) to develop and test interventions in the U.S. and Brazil.

Newswise: UM School Of Medicine Researchers Receive NIH Avant Garde Award For Out-Of-Box, Innovative Concept To Cure HIV And Treat Co-Existing Addiction
Released: 6-Jul-2021 7:05 AM EDT
UM School Of Medicine Researchers Receive NIH Avant Garde Award For Out-Of-Box, Innovative Concept To Cure HIV And Treat Co-Existing Addiction
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Professor of Diagnostic Radiology & Nuclear Medicine, Linda Chang, MD, MS, received the National Institute on Drug Abuse (NIDA) 2021 Avant Garde Award (DP1) for HIV/AIDS and Substance Use Disorder Research — a National Institutes of Health (NIH) Director’s Pioneer Award.

Released: 30-Jun-2021 6:25 PM EDT
艾滋病毒/艾滋病的40年历程
Mayo Clinic

今年6月是描述肺囊虫性肺炎的第一份科学报告发表40周年,肺囊虫性肺炎就是后来众所周知的获得性免疫缺陷综合症(AIDS),即艾滋病。根据美国疾病控制和预防中心的数据,迄今为止全球已有超过3,200万人死于艾滋病,另外有3,800万人感染了可引发艾滋病的人类免疫缺陷病毒(HIV),即艾滋病毒。

Newswise: Wistar Scientists Discover Blood-based Biomarkers to Predict HIV Remission After Stopping Antiretroviral Therapy
Released: 29-Jun-2021 10:05 AM EDT
Wistar Scientists Discover Blood-based Biomarkers to Predict HIV Remission After Stopping Antiretroviral Therapy
Wistar Institute

New biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are critical for the development of new therapeutic strategies that can achieve infection control without ART, a condition defined as functional cure. Wistar Scientists have identified metabolic and glycomic signatures in the blood of a rare population of HIV-infected individuals who can naturally sustain viral suppression after ART cessation, known as post-treatment controllers. T

Released: 28-Jun-2021 11:05 AM EDT
Researcher Receives NIH Director’s Award to Help End HIV Global Epidemic
Albert Einstein College of Medicine

International organizations and countries around the world are working to eliminate HIV/AIDS by 2030. To reach this goal, new approaches are needed—particularly among difficult-to-reach groups such as people who inject drugs (PWID), who are 30 times more likely to contract HIV/AIDS compared with the general population.


Showing results

51100 of 1611

close
1.29135